B. Iung and A. Vahanian, Epidemiology of acquired valvular heart disease, Can J Cardiol. sept, vol.30, issue.9, pp.962-70, 2014.

C. Rostagno, Heart valve disease in elderly, World J Cardiol. 26 févr, vol.11, issue.2, pp.71-83, 2019.

V. T. Nkomo, J. M. Gardin, T. N. Skelton, J. S. Gottdiener, C. G. Scott et al., Burden of valvular heart diseases: a population-based study, Lancet Lond Engl. 16 sept, vol.368, issue.9540, pp.1005-1016, 2006.

P. Kong, P. Christia, and N. G. Frangogiannis, The pathogenesis of cardiac fibrosis, Cell Mol Life Sci CMLS. févr, vol.71, issue.4, pp.549-74, 2014.

P. Debonnaire, V. Delgado, and J. J. Bax, Potential role of fibrosis imaging in severe valvular heart disease, Heart Br Card Soc. mars, vol.101, issue.5, pp.397-407, 2015.

M. Su, L. Lin, Y. Tseng, C. Chang, C. Wu et al., CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF, JACC Cardiovasc Imaging. oct, vol.7, issue.10, pp.991-998, 2014.

R. Querejeta, B. López, A. González, E. Sánchez, M. Larman et al., Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis, Circulation. 7 sept, vol.110, issue.10, pp.1263-1271, 2004.

M. Nguyen, H. Kiriazis, X. Gao, and X. Du, Cardiac Fibrosis and Arrhythmogenesis. Compr Physiol, vol.18, pp.1009-1058, 2017.

M. Disertori, M. Masè, and F. Ravelli, Myocardial fibrosis predicts ventricular tachyarrhythmias, Trends Cardiovasc Med, vol.27, issue.5, pp.363-72, 2017.

A. H. Bui, S. Roujol, M. Foppa, K. V. Kissinger, B. Goddu et al., Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia, Heart Br Card Soc, vol.103, issue.3, pp.204-213, 2017.

D. Kitkungvan, F. Nabi, R. J. Kim, R. O. Bonow, M. A. Khan et al., Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse, J Am Coll Cardiol. 21 août, vol.72, issue.8, pp.823-857, 2018.

H. Baumgartner, V. Falk, J. J. Bax, D. Bonis, M. Hamm et al., , 2017.

. Esc/eacts, Guidelines for the management of valvular heart disease, Eur Heart J. 21 sept, vol.38, issue.36, pp.2739-91, 2017.

R. A. Nishimura, C. M. Otto, R. O. Bonow, B. A. Carabello, J. P. Erwin et al., , 2017.

. Aha/acc, AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, vol.20, p.135, 2014.

E. Quintana, R. M. Suri, N. M. Thalji, R. C. Daly, J. A. Dearani et al., Left ventricular dysfunction after mitral valve repair--the fallacy of « normal » preoperative myocardial function, J Thorac Cardiovasc Surg. déc, vol.148, issue.6, pp.2752-60, 2014.

T. Matsumura, E. Ohtaki, K. Tanaka, K. Misu, T. Tobaru et al., Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair, J Am Coll Cardiol. 6 août, vol.42, issue.3, pp.458-63, 2003.

M. Enriquez-sarano, A. J. Tajik, H. V. Schaff, T. A. Orszulak, M. D. Mcgoon et al., Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications, J Am Coll Cardiol, vol.24, issue.6, pp.1536-1579, 1994.

A. S. Flett, D. M. Sado, G. Quarta, M. Mirabel, D. Pellerin et al., Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study, Eur Heart J Cardiovasc Imaging, vol.13, issue.10, pp.819-845, 2012.

C. Tribouilloy, D. Rusinaru, C. Szymanski, S. Mezghani, A. Fournier et al., Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive value of left ventricular end-systolic dimension to ejection fraction, Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. sept, vol.12, issue.9, pp.702-712, 2011.

S. M. Dusenbery, M. Jerosch-herold, C. Rickers, S. D. Colan, T. Geva et al., Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis, J Am Coll Cardiol. 6 mai, vol.63, issue.17, pp.1778-85, 2014.

A. Singh, C. D. Steadman, and G. P. Mccann, Advances in the understanding of the pathophysiology and management of aortic stenosis: role of novel imaging techniques, Can J Cardiol. sept, vol.30, issue.9, pp.994-1003, 2014.

E. B. Schelbert, K. M. Piehler, K. M. Zareba, J. C. Moon, M. Ugander et al.,

, Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage, J Am Heart Assoc. 18 déc, vol.4, issue.12, 2015.

R. Bing, J. L. Cavalcante, R. J. Everett, M. Clavel, D. E. Newby et al., Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis, JACC Cardiovasc Imaging. févr, vol.12, issue.2, pp.283-96, 2019.

C. De-meester-de-ravenstein, C. Bouzin, S. Lazam, J. Boulif, M. Amzulescu et al., Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T, J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson. 11 juin, vol.17, p.48, 2015.

F. Aus-dem-siepen, S. J. Buss, D. Messroghli, F. Andre, D. Lossnitzer et al., T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy, Eur Heart J Cardiovasc Imaging. févr, vol.16, issue.2, pp.210-216, 2015.

T. A. Treibel, R. Kozor, R. Schofield, G. Benedetti, M. Fontana et al., Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis, J Am Coll Cardiol. 27 févr, vol.71, issue.8, pp.860-71, 2018.

C. Chin, R. J. Everett, J. Kwiecinski, A. T. Vesey, E. Yeung et al., Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis, JACC Cardiovasc Imaging, vol.10, issue.11, pp.1320-1353, 2017.

J. Bergler-klein, M. Gyöngyösi, and G. Maurer, The role of biomarkers in valvular heart disease: focus on natriuretic peptides, Can J Cardiol. sept, vol.30, issue.9, pp.1027-1061, 2014.

D. Arangalage, V. Nguyen, T. Robert, M. Melissopoulou, T. Mathieu et al., Determinants and prognostic value of Galectin-3 in patients with aortic valve stenosis, Heart Br Card Soc, vol.01, issue.11, pp.862-870, 2016.

K. A. Kortekaas, G. E. Hoogslag, R. A. De-boer, M. M. Dokter, M. Versteegh et al., Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair, Eur J Heart Fail. sept, vol.15, issue.9, pp.1011-1019, 2013.

S. Mascle, F. Schnell, C. Thebault, H. Corbineau, M. Laurent et al., Predictive value of global longitudinal strain in a surgical population of organic mitral regurgitation, J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. juill, vol.25, issue.7, pp.766-72, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00905345

T. G. Witkowski, J. D. Thomas, P. Debonnaire, V. Delgado, U. Hoke et al., Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair, Eur Heart J Cardiovasc Imaging. janv, vol.14, issue.1, pp.69-76, 2013.

D. R. Messroghli, A. Radjenovic, S. Kozerke, D. M. Higgins, M. U. Sivananthan et al., Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart, Magn Reson Med. juill, vol.52, issue.1, pp.141-147, 2004.

A. F. Members, A. Vahanian, O. Alfieri, F. Andreotti, M. J. Antunes et al., Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, vol.33, pp.2451-96, 2012.

K. T. Weber and C. G. Brilla, Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system, Circulation. juin, vol.83, issue.6, pp.1849-65, 1991.

B. Pitt, F. Zannad, W. J. Remme, R. Cody, A. Castaigne et al., The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators, N Engl J Med. 2 sept, vol.341, issue.10, pp.709-726, 1999.